Overview
The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries.
In India, CHAI works in partnership with its India registered affiliate William J Clinton Foundation (WJCF) under the guidance of the Ministry of Health and Family Welfare (MoHFW) at the Central and States\' levels on an array of high priority initiatives aimed at improving health outcomes. Currently, WJCF supports government partners across projects to expand access to quality care and treatment for HIV/AIDS, Hepatitis, tuberculosis, COVID-19, common cancers, sexual and reproductive health, immunization, and essential medicines.
Learn more about our exciting work: http://www.clintonhealthaccess.org
Project background
According to the World Health Organization\xe2\x80\x99s Global TB report 2022, an estimated 10.6 million people fell ill with tuberculosis (TB) in 2021, an increase of 4.5% from 2020, and ~1.6 million people died from TB. The burden of drug-resistant TB (DR-TB) also increased by 3% between 2020 and 2021 with ~450 000 new cases of rifampicin-resistant TB (RR-TB) in 2021. This is the first time in many years that an increase has been reported in the number of people falling ill with TB and drug resistant TB.
TB services were among many others severely disrupted by the COVID-19 pandemic in 2021, but its impact on the TB response has been particularly severe. There is, thus, an urgent need for strategies to mitigate the impact of the COVID-19 pandemic and initiate urgent improvements in formal and community health systems.
Under the COVID-19 Response Mechanism (C19RM) of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), WJCF is currently undertaking an active-case finding initiative to increase TB case-finding and address delays in diagnosis and treatment. Recognising the criticality of chest X-ray as a diagnostic tool, ultraportable handheld chest X-ray machines (dCXR) with integrated Computer-Aided Detection (CAD) software are currently being procured and deployed at identified Primary Healthcare Centers across multiple districts in nine states to generate evidence and demonstrate various use cases for wider adoption and scale-up. To that end, our teams conduct highly targeted community mobilisation for screening in co-ordination with Front Line Workers (FLWs). Individuals are first screened for symptoms & vulnerabilities and provided access to chest X-rays with those observed to be suggestive of TB being linked to diagnostic testing and treatment.
As a next step to ensure the current C19RM intervention is scaled up, WJCF, under the aegis of the National TB Elimination Program (NTEP) and the Country Coordinating Mechanism (CCM), will be assisting in procurement of an additional 175 dCXR + CAD units to augment active case-finding efforts under the NTEP in multiple States and screening infrastructure at the primary health facility level, at key identified primary health facilities, thereby democratising the screening tool. As part of this procurement, WJCF shall undertake: (1) A detailed needs assessment for optimal allocation of the units, (2) An RFP and a subsequent proposal evaluation process to identify the right vendor(s) to engage with (3) coordination with States to ensure smooth delivery.
Position summary
The Project Manager will be a core member of the Project Management Unit (NPMU) for the C-19RM + CCM project, based out of the WJCF Delhi office and report to the Project Director. The successful candidate will lead all the activities to achieve the project goals that, inter alia, include needs assessment, area and facility identification for device allocation, vendor selection, while engaging with stakeholders.
WJCF is seeking a highly motivated individual with outstanding credentials, strategic thinking, project management, communication skills and technical expertise. The candidate must be able to function independently and flexibly and have a strong commitment to excellence. WJCF places great value on relevant personal qualities: resourcefulness, responsibility, tenacity, independence, energy, and work ethic.
Responsibilities
MNCJobsIndia.com will not be responsible for any payment made to a third-party. All Terms of Use are applicable.